The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...
Danish drugmaker Novo Nordisk will invest 864 million reais ($158.2 million) to revamp a plant in Brazil responsible for ...
Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with ...
Novo Nordisk's decision to stop insulin pen production poses a serious challenge to diabetes care in South Africa, where ...
Zacks.com users have recently been watching Novo Nordisk (NVO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli ...
Friday’s jobs report could bolster the view that the American economy is holding steady, but an oil price shock could ...
The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx face growing criticism over ...
BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, whose top-selling diabetes ...
The most recent U.S. Food and Drug Administration inspection of Thermo Fisher's Greenville plant in May identified ...
Texas Attorney General Ken Paxton alleges several major manufacturers and pharmacy benefit managers have driven the costs of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback